Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
if reduced appetite is affecting nutritional intake, seek dietetic advice If injection site reactions are persistent or worsening, inform the trial team or supervising clinician promptly
In stock (can be backordered) Retatrutide 30mg Research Overview Retatrutide 30mg is a next-generation multi-agonist peptide investigated in metabolic research for its activity at GLP-1, GIP, and glucagon receptors
It balances concentration with measurability, giving you enough precision for starting doses while keeping injection volumes reasonable at higher doses
Explore Health Resources Learn where our story began, and how we continue to evolve alongside our customers
US$ 25.03
US$ 21.18
US$ 23.58
US$ 24.94
US$ 20.78
US$ 25.26
US$ 24.85
US$ 24.78
US$ 26.95
US$ 20.33
